Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department
NCT ID: NCT04846322
Last Updated: 2024-03-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2021-03-01
2022-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determining the Preliminary Efficacy of the Emergency Department Delirium Screening and Detection Program
NCT05638945
Delirium Screening of the Elderly in the Emergency Department
NCT02801851
ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care
NCT06079203
Implementation Outcome Assessments of the Emergency Department Delirium Screening and Detection Program
NCT05606328
Delirium in the Emergency Department and Its Extension Into Hospitalization
NCT01651897
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ED delirium & dementia screening & outpatient referral
Routine ED screening for delirium and memory problems with referral for outpatient assessment of cognitive impairment.
PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan)
1. ED assessment for suspected dementia.
2. positive ED patients referred for outpatient clinic cognitive impairment assessment.
3. positive clinic patients referred to primary care with brain health patient plan.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan)
1. ED assessment for suspected dementia.
2. positive ED patients referred for outpatient clinic cognitive impairment assessment.
3. positive clinic patients referred to primary care with brain health patient plan.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Discharged from the adult ED at YNHH or the ED at NMH
Exclusion Criteria
* Alcohol/substance intoxication while in the ED
* Non-English or Non-Spanish speaking
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ula Hwang, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale New Haven Hospital
New Haven, Connecticut, United States
Northwestern
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000029490
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.